Cancer cells typically display altered glucose metabolism characterized by a preference of aerobic glycolysis, known as the Warburg effect, which facilitates cell proliferation. Hypoxia-inducible factor (HIF) and oncoprotein Myc are two prominent transcription factors that drive glycolysis. Previously, we reported that the estrogen-related receptors (ERRs) act as cofactors of HIF and enhance HIF-dependent transcription of glycolytic genes under hypoxia. ERRs are orphan nuclear receptors and key regulators of energy metabolism by orchestrating mitochondrial biogenesis, fatty acid oxidation (FAO) and oxidative phosphorylation. Here, we show that ERRs also stimulate glycolysis under normoxia. ERRs directly bind to and activate promoters of many genes encoding glycolytic enzymes, and the ERR-binding sites in such promoters are essential for ERR-mediated transcriptional activation. ERRs interact with Myc, and the two factors synergistically activate transcription of glycolytic genes. Furthermore, overexpression of ERRs increases glycolytic gene expression and lactate production. Conversely, depletion of ERRs in cancer cells reduces expression of glycolytic genes and glucose uptake, resulting in decreased aerobic glycolysis and cell growth. Taken together, these results suggest that ERRs are important transcriptional activators of the glycolytic pathway and contribute to the Warburg effect in cancer cells.
INTRODUCTION
Glycolysis is the metabolic process through which cells metabolize glucose to pyruvate. In normal differentiated cells under welloxygenated conditions, pyruvate is primarily directed into mitochondria where it is oxidized into acetyl-CoA by the pyruvate dehydrogenase (PDH) complex. Acetyl-CoA then feeds into the tricarboxylic acid (TCA) cycle to generate reducing equivalents, which produce ATP through oxidative phosphorylation (OXPHOS). In hypoxic/anaerobic conditions, pyruvate is shifted from the mitochondrial oxidative pathway and instead is reduced to lactate by lactate dehydrogenase (LDH) in cytoplasm. Glucose metabolism in cancer cells is typically characterized by a shift from aerobic, oxidative metabolism to a glycolytic pathway. Compared with normal cells, cancer cells take up much more glucose and even in the presence of oxygen, most pyruvate derived from glycolysis is diverted into lactate production instead of mitochondrial oxidation. This aerobic glycolysis phenotype is known as the Warburg effect and is a hallmark of cancer cell metabolism. 1 The altered glucose metabolism facilitates cancer cell proliferation, which requires not only ATP but also synthesis of biomass. 2 Many glycolytic intermediates are important external carbon sources and precursors to generate nucleotides, amino acids and lipids. Increased glucose uptake and glycolysis should increase glycolytic ATP production and flux through these synthetic pathways, allowing cancer cells to accommodate both bioenergetic and anabolic demands for assembling new cells. 2 The importance of a proliferative metabolic program in malignancy is exemplified by recently discovered amplification of the PHGDH gene in human cancer. 3, 4 PHGDH encodes phosphoglycerate dehydrogenase, which directs a glycolytic metabolite into synthesis of serine and glycine, and contributes to cancer cell proliferation. 3, 4 Metabolic switch to aerobic glycolysis in cancer cells is driven primarily by oncogenic signaling pathways involving kinases, such as PI3K and Akt, and transcription factors, most notably, hypoxiainducible factor (HIF) and Myc. [5] [6] [7] [8] [9] Either because of an intratumoral hypoxic microenvironment or as a result of genetic defects, HIF is stabilized in cancer cells. HIF directly binds to and activates transcription of glucose transporter and nearly every gene in the glycolytic pathway. 10 Meanwhile, HIF upregulates PDH kinase (PDK) 1, which in turn inhibits the PDH complex, a rate-limiting enzyme for glucose oxidation. [11] [12] [13] Therefore, HIF induces a dramatic reprogramming of cancer cell metabolism involving increased glucose uptake and glycolytic flux, and concomitantly decreased glucose oxidation. Many genes encoding glycolytic enzymes are also direct targets of Myc. 14 Myc enhances glycolysis without hypoxia. Furthermore, HIF and Myc, both of which are highly expressed in most tumor types, collaborate to direct a transition to glycolytic metabolism during cell proliferation or tumorigenesis. 7 We recently identified the estrogen-related receptors (ERRs) a, b and g (NR3B1, 2 and 3) as coactivating factors of HIF. 15 ERRs interact with HIF and enhance HIF-induced glycolytic and angiogenic gene expression under hypoxia. 15 ERRs are orphan nuclear receptors that are constitutively active without exogenously added ligands, although their transcription activity is further augmented in the presence of coactivator proteins, in particular the PGC-1 family of coregulatory proteins. 16, 17 Expressed mostly in tissues with high metabolic demands, ERRs have a predominant role in orchestrating mitochondrial biogenesis and cellular energy metabolism such as OXPHOS, TCA cycle, fatty acid oxidation (FAO) and ATP synthesis. 16 ERRs directly activate transcription of numerous genes involved in mitochondrial oxidative metabolism. Consistently, engineered ablation of ERRa or ERRg in mice results in impaired mitochondrial biogenesis and oxidative capacity in heart muscle, fat cells and macrophages. 16 Glucose and fatty acids compete for their oxidation, which is described as the Randle cycle. 18 While promoting FAO, ERRs inhibit glucose oxidation by upregulating PDK4. [19] [20] [21] Like PDK1, PDK4 inactivates PDH and decreases glucose carbon flux into TCA. The similar activity of ERRs and HIF in blocking glucose oxidation and their collaboration in hypoxic gene transcription prompted us to examine whether ERRs might also directly regulate glycolysis. Accumulating evidence implicates ERRs in the glycolysis pathway. Genome-wide chromatin immunoprecipitation (ChIP)-based binding studies in mouse and human cells revealed the occupancy of ERRs not only at genes of oxidative metabolism but also at glycolytic gene loci. [22] [23] [24] Moreover, the Drosophila ortholog of ERR, dERR, is required for induction of glycolysis to support cell proliferation during mid-embryonic development. 25 The fly Pfk glycolytic gene is a direct transcriptional target of dERR, and most glycolytic genes and lactate levels are significantly downregulated in dERR mutants. 25 ERRa has been identified as a negative prognosticator in breast and other cancers, and its expression generally correlates with advanced tumor stage and histological grading. 26, 27 ERRg mRNA was found to be overexpressed in 75% of the breast tumors compared with normal mammary epithelial cells, and its overexpression is associated with estrogen receptor-positive status, and thus, antiestrogen sensitivity and a favorable prognosis. 26 Depletion of ERRa in the MDA-MB-231 breast cancer cells decreases the growth rate of tumor xenografts. 28 Given that altered metabolism is vital for tumor growth and that ERRs are global metabolic regulators, we investigated whether ERRs might regulate glucose metabolism in cancer. In the present study, we confirmed that ERRs bind to promoters of many glycolytic genes and activate their expression through the ERR-binding sites. ERRs interact and synergize with Myc in activation of glycolytic genes. Overexpression of ERRs increases glycolytic gene expression and lactate production; conversely, depletion of ERRs in cancer cells downregulates the aerobic glycolytic phenotype and cell growth. Collectively, these findings suggest that ERRs promote glycolysis, and together with wellestablished glycolysis-driving transcription factors Myc and HIF, contribute to the metabolic transformation of cancer cells.
RESULTS
ERRs bind to promoters of glycolytic enzyme genes By examining the ChIP-seq-based global transcription factorbinding database from the ENCODE Consortium, we found that ERRa occupies the transcription start sites and/or extended promoter regions of most glycolytic genes such as ENO1, PKM2 and LDHA in HepG2 human liver cells (Supplementary Figure S1 ; Supplementary Table S1 ). An Enhancer Elements Locator (EEL) program identified putative ERR-binding motifs (ERREs) in the ERRa-bound glycolytic gene promoters. To confirm the binding of ERR, we designed corresponding primers and performed ChIP analysis in MCF7 human breast cancer cells. Compared with control immunoglobin G, the ERRa antibody significantly enriched genomic DNA fragments of HK2, ALDOC, ENO1, PKM2 and LDHA promoters ( Figure 1a ). As antibodies for ERRg suitable for ChIP analysis were not available, MCF7 cells were transduced with lentivirus expressing TetON-inducible Flag-tagged ERRg. Upon induction with a low concentration of Doxcyclin, cells were subjected to ChIP analysis with anti-Flag antibody. Significant binding of Flag-ERRg was observed at these glycolytic gene promoters as well ( Figure 1b ). These results confirm that ERRs bind to promoter regions of glycolytic genes in cancer cells.
ERRs activate glycolytic gene promoters through ERREs
The presence of ERRs at glycolytic genes prompted us to examine their effect on transcription of these genes. The PKM2 proximal promoter contains two putative ERREs (Figure 2a ). When this promoter was linked to a Luciferase reporter, ERRg significantly activated the reporter when co-transfected into HEK293 cells (Figure 2a ). This activation was further enhanced in the presence of exogenous PGC-1 proteins, which are coactivators of ERRs (Figure 2a ). ERRa only possessed weak transcriptional activities in vitro, and did not significantly stimulate reporter activity. To verify if ERRg activated through direct binding to the promoter, we individually mutated the two ERREs in the PKM2 promoter. While one ERRE was dispensable, the other was essential for ERRgmediated reporter activation (Figure 2b) .
Similarly, we analyzed the promoter of ENO1, which also harbors two potential ERREs (Figure 2c ). A control reporter carrying the basal promoter of PDK4 was not responsive to ERRs under all experimental conditions ( Figure 2c ). When an ENO1 5 0 upstream fragment was inserted in front of the basal promoter, the resulting reporter was activated mildly by ERRa but robustly by ERRg ( Figure 2c ). Addition of PGC-1 proteins further markedly augmented activation by both ERRa and ERRg (Figure 2c ). Mutation of one ERRE (site 1) in the ENO1 promoter substantially impaired ERRg-mediated activation, and mutation of the other ERRE (site 2) completely abolished induction of reporter by ERRg ( Figure 2d ), suggesting both ERREs are required for ERRdependent activation of the ENO1 promoter. The reporter assays Figure S1) . Intriguing, the occupancy of Myc overlaps with that of ERRa (Supplementary Figure S1 ). We tested whether Myc may influence ERR's activation of glycolytic genes in reporter-based assays. Myc alone exerted only very mild effect on the reporter construct carrying either PKM2 or ENO1 promoter (Figures 3a and b) . Remarkably, in the presence of exogenous ERRg, Myc and ERRg synergistically activated both reporters (for example, 70 fold induction of the ENO1 promoter-driven reporter) (Figures 3a and  b ). Myc also synergized with ERRa on the ENO1 reporter, albeit to a milder extent. Mutation of the critical ERREs in these reporters absolutely abrogated such synergy (Figures 3a and b ), suggesting that binding of ERRs to DNA is essential for the cooperative activation by ERRs and Myc.
Given their overlapping binding pattern and synergy in reporter activation, we wondered whether ERR might interact with Myc. Myc and Flag-tagged ERRg were co-transfected into HEK293 cells. Immunoprecipitation (IP) of ERRg from cellular lysates with anti-Flag antibody pulled down exogenous Myc (endogenous Myc was not detectable) ( Figure 3c ). Similarly, a reciprocal assay with anti-Myc antibody for IP also detected ERR-Myc association (Figure 3d ). These data suggest that ERR and Myc form a complex and co-regulate glycolytic genes.
Overexpression of ERRs activates endogenous glycolytic genes and enhances aerobic glycolysis
To investigate the effect of ERRs on transcription of endogenous glycolytic genes, we generated lentivirus expressing either Flagtagged ERRa or ERRg, and transduced MCF7 cells. Expression of ERRs was validated by immunoblotting analysis. Exogenous ERRa was expressed at much higher levels than the endogenous one ( Figure 4a ). Overexpression of ERRa evidently increased protein expression of LDHA ( Figure 4a ). Forced expression of ERRg led to an even stronger effect. In ERRg-overexpressing cells, LDHA protein level was dramatically increased, and ENO1 expression was also elevated as compared with control cells (Figure 4a ).
To quantify the induction of glycolytic genes by forced expression of ERRs in MCF7 cells, real-time RT-PCR was performed to measure mRNA levels of glycolytic genes, including LDHA, ENO1, HK2, ALDOC, PKM2, TPI1 and GAPDH. A few known ERR target genes, such as IDH1, IDH3a and MDH2, which encode enzymes involved in mitochondrial metabolism, were included for comparison. Both ERRa and ERRg stimulated expression of these glycolytic genes to varying degrees (Figure 4b ). Activation of endogenous glycolytic genes by ectopic expression of ERRs was also observed in MDA-MB-231 human breast cancer cells (Supplementary Figure S2a) .
Consistent with elevated expression of enzymes in the glycolytic pathway, in particular LDHA, lactate concentrations in media of MCF7 cells were also stimulated by overexpression of ERRa and ERRg, the latter had a more potent effect (Figure 4c) . ERRs similarly increased lactate production in MDA-MB-231 cells (Supplementary Figure S2b) .
Depletion of ERRs reduces glycolytic gene expression, glucose uptake, ATP and lactate levels, and growth rate in cancer cells Cancer cells exhibit increased glycolysis even under normoxic conditions. As exogenous ERRs enhanced glycolysis, we asked whether the glycolytic phenotype of cancer cells might be (in part) attributable to the endogenous ERRs. ERRa or ERRg was each depleted in MCF7 cells with two independent lentiviral short hairpin RNAs (shRNAs). Efficient knockdown of endogenous ERRa was confirmed by immunoblotting analysis (not shown), and depletion of ERRg was verified by quantitative RT-PCR (Figure 5a ). Depletion of either ERRa or ERRg significantly downregulated RNA expression of HK2, ENO1 and LDHA (Figure 5a ). PKM2 RNA levels decreased only in ERRg-depleted, but not ERRa-depleted MCF7 cells (Figure 5a ). We also examined other cancer cell lines for gene regulation by ERR and confirmed that expression of endogenous HK2, ENO1, LDHA and PKM2 was largely dependent on both ERRs in T47D and MDA-MB-435 cells as well (Figure 5b and Supplementary Figure S3a , respectively).
Reduced expression of glycolytic enzymes is expected to lead to reduced glycolysis rates. Therefore, we determined the effect of depletion of ERRs on aerobic glycolysis. Compared with control MCF7 cells, cells depleted of ERRs exhibited markedly decreased glucose consumption ( Figure 6a ) and lactate production ( Figure 6b ). In addition to generation of energy and metabolites, cellular metabolism converts substrates into byproducts lactate and CO 2 , which are released into the environment and cause extracellular acidification. Under typical cell culture conditions, extracellular acidification by cancer cells is dominated by lactic acid derived from glycolysis. Consistent with reduced lactate production, ERR-depleted MCF7 cells displayed weaker capacity to decrease medium pH values than control cells (Figure 6c ). Elevated aerobic glycolysis represents an integral source for energy production in cancer cells. As expected, in ERR-depleted cells in which glycolysis was impaired, cellular ATP levels also declined (Figure 6d ). Although glucose oxidation is generally attenuated in cancer cells, OXPHOS is still functional to certain extent and contributes to ATP generation. Oligomycin, an inhibitor of the F1F0 ATP synthase, suppresses OXPHOS and mitochondrial ATP synthesis. In response to oligomycin treatment, cancer cells upregulate glycolysis as a compensatory mechanism for ATP generation to sustain ATP levels. 29 When MCF7 cells were exposed to oligomycin, cellular ATP levels in ERR-depleted cells were significantly lower than those in control cells (Figure 6d ). Collectively, these bioenergetic measurements suggest that endogenous ERRs contribute to the aerobic glycolysis phenotype of cancer cells.
Increased glucose consumption and glycolysis facilitate cell proliferation by meeting both bioenergetic and anabolic needs of dividing cells. As depletion of ERRs reduced glycolysis, it was anticipated that cell growth would be affected as well. MCF7 cells depleted of ERRg demonstrated modestly yet significantly reduced growth rate compared with control cells (Figure 6e ), but depletion of ERRa did not have a clear effect (Figure 6e ). In T47D cells, depletion of either ERRa or ERRg significantly impaired cell growth (Figure 6f ). Similar phenomenon was also observed in MDA-MB-435 cells (Supplementary Figure S3b) . These results suggest that ERRs are modulators of cancer cell growth.
DISCUSSION
Aerobic glycolysis, or the Warburg effect, is a characteristic feature of cancer cells. The altered glucose metabolic profile satisfies the unique bioenergetic and anabolic requirement of proliferating cancer cells. HIF and Myc are two prominent drivers of the Warburg effect. Here, we identified the orphan nuclear receptor ERRs as global activators of glycolysis and important contributors to the glycolytic phenotype in cancer cells. ERRs recognize the promoter regions of many genes encoding enzymes in the glycolytic pathway. ERRs activate glycolytic genes through the ERREs in these promoters. Overexpression and depletion of ERRs enhance and reduce glycolytic gene expression and aerobic glycolysis in cancer cells, respectively. Together with our previous report, 15 the current study suggests that ERRs can collaborate with both Myc and HIF in activating glycolytic gene expression, reinforcing the important role of ERRs in induction of glycolysis and metabolic transformation of cancer. ERRs have been implicated in tumor growth and progression. 26, 27 ERRs may contribute to malignant development in part by conferring metabolic advantages to tumor cells.
According to the Randle cycle, 18 oxidation of glucose and fatty acids is reciprocally inhibitory. FAO produces acetyl-CoA, which enters the TCA cycle to generate NADH. Both acetyl-CoA and NADH can inhibit the PDH complex, uncoupling glycolysis from subsequent oxidation. 18 ERRs are known to promote oxidative metabolism of fatty acids by activating genes critical for mitochondrial uptake and b-oxidation of fatty acids. 16 By enhancing FAO and inhibiting glucose oxidation through upregulation of PDK4, ERRs may be part of the regulatory mechanism underlying the Randle cycle and metabolic substrate selectivity. However, the two FAO products do not directly inhibit glycolysis. Consequently, unlike glucose oxidation, glycolysis is compatible with FAO. Indeed, inhibition of glucose oxidation by FAO should further diverts pyruvate to lactate, and hence enhance aerobic glycolysis. Therefore, stimulation of glycolysis by ERRs does not necessarily conflict with ERRs' existing role in FAO. This metabolic control is reminiscent of AMPK, a key kinase in energy metabolism. AMPK orchestrates cellular energy conservation by activating catabolic pathways, including glucose uptake, glycolysis and FAO. 30 Cancer cells generally retain intact mitochondrial function. While they exhibit a shift from glucose oxidation to glycolysis, cancer cells may have varying degrees of oxidative metabolism, probably depending availability of oxygen and fuel types (for example, glutamine and fatty acids). 31 Oxidative metabolism also feeds the energetic and anabolic demands of dividing cells: the TCA cycle supplies important intermediates for lipid and amino-acid biosynthesis, and OXPHOS efficiently generates ATP. 2, 9 ERRs are master regulators of mitochondrial oxidative metabolism including the TCA cycle and OXPHOS. 16 The finding that ERRs also promote glycolysis suggests that the two main metabolic pathways can be integrated under the control of a common transcription factor, which may offer growth advantages to cancer cells. Although different ERR members may function differently (for example, depending on cell types), 32 ERR-expressing cancer cells may rely on different metabolic programs to adapt to nutrient supply, oxygen availability and energy demand. In this regard, Myc stimulates aerobic glycolysis as well as mitochondrial respiration and glutaminolysis. 33, 34 Anti-glycolysis treatment as monotherapy so far only results in a limited effect on tumorigenesis, 8 which might be attributed to tumor's ability to switch from glucose dependence to a reliance on oxidative metabolism of other fuels.
MATERIALS AND METHODS

Plasmids, antibodies and mice
Full-length human ERRa, ERRg, PGC-1a and PGC-1b cDNAs were amplified by PCR and cloned into pcDNA3 (Invitrogen, Carlsbad, CA, USA) with a Flag epitope tag at the amino-terminus. Lentiviral expression vectors for Flag-ERRa-IRES-Puro and Flag-ERRg-IRES-Puro were made in the pGIPz vector (OpenBiosystems, Huntsville, AL, USA) by replacing GFP with ERRa or ERRg. TetOn inducible lentiviral expression vector for ERRa and ERRg were made in pTriPz (OpenBiosystems) by replacing RFP and shRNA with ERRa and ERRg. The human PKM2 promoter ( À 284 to þ 271 bp) was PCR amplified and cloned into the pGL4.22 vector (Promega, Madison, WI, USA) for luciferase reporter assays. The rat PDK4 basal promoter region ( À 302 to þ 42 bp) was PCR amplified and cloned into pGL4.22, giving rise to a control reporter called 'C-luc'; subsequently, the ENO1 promoter ( À 1067 to À 328 bp) was amplified and inserted in front of the PDK4 basal promoter in C-luc. Mutagenesis of the putative ERR-binding sites in the PKM2 and ENO1 luciferase reporters was achieved using the QuickChange II Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA). pGIPz-based lentiviral shRNA constructs targeting ERRa and ERRg were from OpenBiosystems. The following antibodies were used in this study: anti-ERRa (Santa Cruz, Santa Cruz, CA, USA and GeneTex, Irvine, CA, USA); anti-ERRg (GeneTex); anti-Flag (Sigma, St Louis, MO, USA); anti-LDHA and anti-ENO1(Cell Signaling, Danvers, MA, USA); anti-tubulin (Sigma). ERRa knockout mutant mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA).
Cell culture, transfection, viral infection, luciferase assay and RT-PCR
The human cell lines HEK293, MCF7, MDA-MB-231, T47D and MDA-MB-435 cells were grown in DMEM medium (Cellgro, Manassas, VA, USA) supplemented with 10% bovine calf serum. All transfections were done using the Turbofect transfection reagent (Fermentas, Glen Burnie, MD, USA) according to the manufacturer's instructions. For the reporter assay, HEK293 cells were transfected with the Luciferase reporter and TK-driven Renilla reporter plasmids, and harvested for Luciferase assays 24 h later. Luciferase activities were determined using the dual Luciferase Reporter Assay System (Promega). Renilla luciferase was used as a reference to normalize transfection efficiency. Data are shown in relative luciferase units and are presented as mean±s.d. from three independent experiments. For RNA isolation and real-time RT-PCR assays, ERRa-IRES-Puro and ERRg-IRES-Puro expressing lentiviruses were used to infect MCF7 and MDA-MB-231 cells; pGIPz ERRa shRNA, ERRg shRNA and empty vector lentiviruses were used to transduce MCF7, T47D and MDA-MB-435 cells. The transduced cells were selected by puromycin (1 mg/ml) for 48 h. Total RNA from cells was extracted with TRIzol reagent (Invitrogen) following the manufacturer's instruction, and cDNA was synthesized using M-MuLV reverse transcriptase with random primers. The expression levels of selected genes were determined by quantitative PCR. Primer sequences were listed in Table S3 .
Co-immunoprecipitation and ChIP
Co-immunoprecipitation assays were performed as previously described. 15 For ChIP assay, cells were cross-linked with 1% formaldehyde for 10 min. The reaction was stopped by the addition of glycine. Cross-linked cells were washed in 1x PBS and collected. Cell pellets were washed in washing buffer (0.25% TritonX-100, 10 mM EDTA, 0.5 mM EGTA, 10 mM Tris pH8.0), resuspended in sonication buffer (1 mM EDTA, 0.5 mM EGTA, 10 mM Tris pH8.0), mixed with glass beads and subjected to sonication. The sonicated samples were diluted in ChIP buffer (0.01% SDS, 1.0% TX-100, 1.0 mM EDTA, 20 mM Tris pH 8.1, 150 mM NaCl) and incubated with specific antibodies and protein A slurry (Invitrogen). The immunoprecipitates were subjected to a series of washing steps to remove non-specific binding. After reverse-crosslinking, the DNA samples were purified and then analyzed by real-time quantitative PCR. Primers used in ChIP assay were listed in Supplementary Table S2 . 
Measurement of lactate concentrations
Lactate concentration was measured using the Lactate assay kit (Biovision, Milpitas, CA, USA) following manufacturer's instruction. Lactate levels in culture media were normalized to cell number, and lactate levels in mice were normalized to protein concentration. Data are presented as mean value ± s.d. from triplicate experiments.
Measurement of glucose uptake and pH
Cells grown at 70% confluence in six-well plates were washed once with fresh DMEM containing 10% fetal bovine serum, and then incubated in 2 ml of the fresh medium for 48 h. The culture medium was collected and analyzed for glucose levels by Glucose Assay Kit (Eton Bioscience, San Diego, CA, USA). Glucose uptake was determined as the difference between glucose level of fresh medium and that of conditioned medium. The cultured medium was also analyzed for pH value using a pH meter.
Measurement of ATP
Cellular ATP changes were measured by Cell Titer-Glo reagent according to the instructions (Promega). Cells grown at 40% confluence in 12-well plates were washed once with fresh DMEM containing 10% bovine calf serum, and then incubated in 500 ml of the fresh medium with or without 5 mM oligomycin for 4 h. The cells were trypsinized and collected to measure ATP by Cell Titer-Glo reagent immediately.
Cell growth assay MCF7, T47D and MDA-MB-435 cells were infected with pGIPz lentivirus and were selected by puromycin (1 mg/ml) for 48 h. Cells were seeded in 12wells plates, and later trypsinized and counted by TC10 Automated Cell Counter (BioRad, Hercules, CA, USA) every 24 h.
Statistical analysis
For all experiments with quantitative results, the data are expressed as the mean and 95% confidence interval from three identical experiments carried out independently. Means and 95% confidence intervals were calculated using Microsoft Office Excel 2007 software.
